DoximityBSP:D2OC34 62 ROA % is 6.56% as of Mar. 2026, which is 66% below its 10-year median of 19.05. GuruFocus rates BSP:D2OC34 with a GF Score™ of 62/100 and a GF Value™ of R$39.99 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 686 Healthcare Providers & Services companies, Doximity ranks better than 95.04% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Doximity's annualizedNet Income for the quarter that ended in Mar. 2026 was R$400 Mil.
Doximity's average Total Assets over the quarter that ended in Mar. 2026 was R$6,094 Mil. Therefore, Doximity's annualized ROA % for the quarter that ended in Mar. 2026 was 6.56%.
The historical rank and industry rank for Doximity's ROA % or its related term are showing as below:
BSP:D2OC34'
s ROA % Range Over the Past 10 Years
Min: 10.6 Med: 19.05 Max: 25.71
Current: 16.32
During the past 8 years, Doximity's highest ROA % was 25.71%. The lowest was 10.60%. And the median was 19.05%.
BSP:D2OC34's ROA % is ranked better than 95.04% of 686
companies
in the Healthcare Providers & Services industry
Industry Median: 1.75
vs BSP:D2OC34: 16.32
Doximity (BSP:D2OC34) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Doximity ROA % Related Terms
Doximity ROA % Historical Data
* Premium members only.
The historical data trend for Doximity's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Doximity's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Doximity ROA % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Doximity's ROA % distribution charts can be found below:
* The bar in red indicates where Doximity's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Doximity (BSP:D2OC34) has a ROA % of 6.56% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Doximity and its competitors. This is 66% below median its historical median of 19.05. Over the past decade, Doximity's ROA % has ranged from 10.60 to 25.71. According to the industry distribution chart, Doximity ranks #34 out of 686 companies in the Healthcare Providers & Services industry, placing it in the top 5%.
Is Doximity's ROA % too high?
Doximity's current ROA % of 6.56% is 66% below median its 10-year median of 19.05. Over the past 10 years, this metric has ranged from a low of 10.60 to a high of 25.71. The Healthcare Providers & Services industry median ROA % is 1.75. Doximity's value of 6.56% is 274.9% above this industry median. Based on the distribution chart, Doximity ranks #34 out of 686 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Doximity has a GF Score™ of 62/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Doximity's ROA % compare to WAY and TXG?
According to the Healthcare Providers & Services industry distribution chart, Doximity ranks #34 out of 686 companies for ROA %. This places Doximity in the top 5% of its industry — outperforming the majority of peers. The industry median ROA % is 1.75. Doximity's value of 6.56% is 274.9% above this benchmark. Historically, Doximity's own ROA % has ranged from 10.60 to 25.71 over the past decade. While the company's 10-year median is 19.05 vs. the industry median of 1.75, Doximity has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Healthcare Providers & Services company?
The median ROA % among Healthcare Providers & Services companies is 1.75, based on 686 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Doximity's current ROA % of 6.56% is 274.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Doximity and its competitors. For the Healthcare Providers & Services industry, the median ROA % is 1.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Doximity's current ROA % is 6.56%, which is 66% below median its own 10-year median of 19.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Doximity stock overvalued right now?
Based on GuruFocus' analysis, Doximity (BSP:D2OC34) is currently considered Significantly Undervalued. The stock's GF Value™ is R$39.99, compared to a current price of R$17.14 — trading 57.1% below its estimated fair value. The current ROA % is 6.56%, which is 66% below median its 10-year median of 19.05 and 274.9% above the Healthcare Providers & Services industry median of 1.75. Doximity's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Doximity (BSP:D2OC34), the current ROA % is 6.56% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Doximity (BSP:D2OC34) Overvalued in 2026?
Based on GuruFocus' analysis, Doximity stock appears to be undervalued.
The current stock price of R$17.14 is trading 57.1% below its estimated GF Value™ of R$39.99.
GuruFocus considers Doximity to be Significantly Undervalued.
Key valuation signals for BSP:D2OC34:
ROA %: 6.56% (66% below median its 10-year median of 19.05)
GF Value™: R$39.99 vs. price of R$17.14 (57.1% below fair value)
Industry Position: 274.9% above the Healthcare Providers & Services median (#34 of 686)
No single metric tells the full story. See the BSP:D2OC34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Doximity Inc provides an online platform, which enables physicians and other healthcare professionals to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The Company's customers include pharmaceutical companies and health systems that connect with healthcare professionals through the Company's digital Marketing, Hiring, and Workflow Solutions. Marketing Solutions provide customers with the ability to share tailored content on the network. Hiring Solutions enable customers to identify, connect with, and hire from the network of both active and passive potential medical professional candidates.
62GF Score
Get the complete analysis for BSP:D2OC34
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:D2OC34 has been successfully added to your 
